ARTICLE | Company News
Moberg Pharma management update
September 8, 2014 7:00 AM UTC
Moberg Pharma AB (SSE:MOB), Bromma, Sweden Business: Dermatology, Neurology Resigning: Steve Cagle as head of U.S. operations, effective January 2015 at the latest ...